Holen Sie sich die Stockscreener-App
0.5911
1.74%
0.0101
Schlusskurs vom Vortag:
$0.581
Offen:
$0.6
24-Stunden-Volumen:
5,961
Relative Volume:
0.16
Marktkapitalisierung:
$3.44M
Einnahmen:
$14.64M
Nettoeinkommen (Verlust:
$-13.74M
KGV:
-0.0813
EPS:
-7.27
Netto-Cashflow:
$-5.04M
1W Leistung:
-12.09%
1M Leistung:
-2.94%
6M Leistung:
-11.18%
1J Leistung:
+9.50%
1-Tages-Spanne:
$0.57
$0.6196
1-Wochen-Bereich:
$0.57
$0.6742
52-Wochen-Spanne:
$0.3611
$1.0099
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
Firmenname
Novabay Pharmaceuticals Inc
Sektor
Branche
Telefon
510-899-8800
Adresse
2000 Powell Street, Suite 1150, Emeryville, CA
Vergleichen Sie NBY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
0.5911 | 3.61M | 14.64M | -13.74M | -5.04M | -7.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.85 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
548.42 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
394.44 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
674.79 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.12 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-09-18 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-07-06 | Bestätigt | H.C. Wainwright | Buy |
| 2017-11-15 | Bestätigt | Laidlaw | Buy |
| 2017-06-05 | Eingeleitet | ROTH Capital | Buy |
| 2017-03-27 | Eingeleitet | Laidlaw | Buy |
| 2017-02-06 | Eingeleitet | Rodman & Renshaw | Buy |
| 2016-03-07 | Herabstufung | Maxim Group | Buy → Hold |
| 2015-12-14 | Bestätigt | Maxim Group | Buy |
| 2015-04-30 | Fortgesetzt | Maxim Group | Buy |
| 2013-03-06 | Eingeleitet | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | Eingeleitet | Dawson James | Speculative Buy |
Alle ansehen
Novabay Pharmaceuticals Inc Aktie (NBY) Neueste Nachrichten
How institutional ownership impacts NovaBay Pharmaceuticals Inc. stockFuture Growth Stock Forecasting Strategy - Newser
Signal strength of NovaBay Pharmaceuticals Inc. stock in tech scannersFree Opportunity Map for Daily Stock Trading - Newser
What MACD signals say about NovaBay Pharmaceuticals Inc.Loss Limitation Strategy Based on Analysis - Newser
What’s next for NovaBay Pharmaceuticals Inc. stock priceSmart Risk Strategy with Entry Optimization - Newser
When is the best time to buy NovaBay Pharmaceuticals Inc. stockTechnical Trade Plan with Entry Checklist - Newser
Can machine learning forecast NovaBay Pharmaceuticals Inc. recoveryTechnical Safety Zone Pattern Recognition - Newser
News impact scoring models applied to NovaBay Pharmaceuticals Inc.Daily Investment Ideas with Market Insight - Newser
Analyzing recovery setups for NovaBay Pharmaceuticals Inc. investorsFree Investment Plan With Growth Optimization - Newser
How Resilient Is NovaBay Pharmaceuticals Inc. Stock During Economic DownturnsVolatility Analysis and Entry Risk Mapping - Newser
Developing predictive dashboards with NovaBay Pharmaceuticals Inc. dataShort Term Opportunity Finder with Tools - Newser
Short interest data insights for NovaBay Pharmaceuticals Inc.Downside Risk Evaluation and Stock Analysis - Newser
Analyzing NovaBay Pharmaceuticals Inc. with multi timeframe chartsGrowth Projection Summary for Long-Term Investors - Newser
Market reaction to NovaBay Pharmaceuticals Inc.’s recent newsLong-Term Investment Strategy Impact Analysis - Newser
Using Ichimoku Cloud for NovaBay Pharmaceuticals Inc. technicalsFree Accurate Technical Trend Reversal Picks - Newser
NovaBay Pharmaceuticals Inc. Price Targets Raised After ReboundFast Gaining Stock Screener Reports Released - metal.it
Why NovaBay Pharmaceuticals Inc. stock attracts strong analyst attentionEntry Optimization Guide with Volume Analysis - Newser
Elliott Wave Theory Predicts Pullback in NovaBay Pharmaceuticals Inc.Weekly Return Pick Forecast Reports Show Trend - metal.it
What makes NovaBay Pharmaceuticals Inc. stock price move sharplyBreakthrough stock performance - jammulinksnews.com
Using data tools to time your NovaBay Pharmaceuticals Inc. exitExpert-Backed High Yield Stock Watchlist - Newser
When is NovaBay Pharmaceuticals Inc. stock expected to show significant growthEarnings Report Ideas With High Returns - jammulinksnews.com
Why NovaBay Pharmaceuticals Inc. stock attracts strong analyst attention Pattern Recognition Based Market Move Prediction - Newser
Short interest data insights for NovaBay Pharmaceuticals Inc. Free Short Term Buy Zone Stock Alerts - Newser
What institutional investors are buying NovaBay Pharmaceuticals Inc. stockAchieve superior capital gains with smart trades - jammulinksnews.com
Should I hold or sell NovaBay Pharmaceuticals Inc. stock in 2025Capitalize on emerging industry trends - jammulinksnews.com
Is NovaBay Pharmaceuticals Inc. stock overvalued or undervaluedGet timely alerts on top market movers - jammulinksnews.com
How does NovaBay Pharmaceuticals Inc. compare to its industry peersBreakthrough profit margins - jammulinksnews.com
Buy Signal for NovaBay Pharmaceuticals Inc. Stock Key Technical Indicators to WatchHigh Probability Setups - Newser
Is NovaBay Pharmaceuticals Inc. a good long term investmentUnmatched market gains - PrintWeekIndia
How NovaBay Pharmaceuticals Inc. stock reacts to Fed policy changesMarket-leading growth rates - jammulinksnews.com
What analysts say about NovaBay Pharmaceuticals Inc. stockFree Market Dynamics Reports - PrintWeekIndia
NovaBay Pharmaceuticals Inc. Stock Analysis and ForecastUnbelievable profit margins - PrintWeekIndia
What drives NovaBay Pharmaceuticals Inc. stock priceFree Investment Risk Control - Autocar Professional
Finanzdaten der Novabay Pharmaceuticals Inc-Aktie (NBY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):